We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HI
776
DELISTED
Hillenbrand
HI
| $25K | ﹤0.01% |
+618
| New | +$21.3K |
|
777
Intuitive Surgical
ISRG
$135B
| $25K | ﹤0.01% |
+93
| New | +$23.1K |
|
778
Methode Electronics
MEI
$499M
| $25K | ﹤0.01% |
+663
| New | +$22.7K |
|
779
Myriad Genetics
MYGN
$285M
| $25K | ﹤0.01% |
+1,258
| New | +$20.3K |
|
780
Pitney Bowes
PBI
$2.48B
| $25K | ﹤0.01% |
+4,118
| New | +$24.7K |
|
781
Schwab US TIPS ETF
SCHP
$16.2B
| $25K | ﹤0.01% |
+824
| New | +$25.3K |
|
782
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.37B
| $25K | ﹤0.01% |
+489
| New | +$25.5K |
|
783
Steris
STE
$22.7B
| $25K | ﹤0.01% |
+131
| New | +$24.4K |
|
784
Viavi Solutions
VIAV
$9.31B
| $25K | ﹤0.01% |
+1,648
| New | +$21.9K |
|
785
World Acceptance Corp
WRLD
$877M
| $25K | ﹤0.01% |
+247
| New | +$26.1K |
|
|
MRO
786
DELISTED
Marathon Oil Corporation
MRO
| $25K | ﹤0.01% |
+3,783
| New | +$20.3K |
|
|
BIG
787
DELISTED
Big Lots, Inc.
BIG
| $25K | ﹤0.01% |
+585
| New | +$28.4K |
|
|
BBBY
788
DELISTED
Bed Bath & Beyond Inc
BBBY
| $25K | ﹤0.01% |
+1,383
| New | +$28.7K |
|
|
LDL
789
DELISTED
Lydall, Inc.
LDL
| $25K | ﹤0.01% |
+826
| New | +$19.9K |
|
|
VAR
790
DELISTED
Varian Medical Systems, Inc.
VAR
| $25K | ﹤0.01% |
+145
| New | +$25.1K |
|
791
Albemarle
ALB
$14B
| $24K | ﹤0.01% |
+163
| New | +$19.4K |
|
792
Alamo Group
ALG
$1.99B
| $24K | ﹤0.01% |
+176
| New | +$22.8K |
|
793
APA Corp
APA
$13B
| $24K | ﹤0.01% |
+1,664
| New | +$19.4K |
|
794
Baxter International
BAX
$14.5B
| $24K | ﹤0.01% |
+298
| New | +$23.6K |
|
795
Becton Dickinson
BDX
$46.9B
| $24K | ﹤0.01% |
+99
| New | +$23.1K |
|
796
Caleres
CAL
$470M
| $24K | ﹤0.01% |
+1,561
| New | +$17.5K |
|
797
ConocoPhillips
COP
$145B
| $24K | ﹤0.01% |
+612
| New | +$22.6K |
|
798
DuPont de Nemours
DD
$19.1B
| $24K | ﹤0.01% |
+268
| New | +$21K |
|
799
VanEck Gold Miners ETF
GDX
$23.2B
| $24K | ﹤0.01% |
+670
| New | +$25K |
|
800
Mastercard
MA
$500B
| $24K | ﹤0.01% |
+67
| New | +$22.3K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.